Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Rectal CancerLocally Advanced Rectal CancerHyperthermiaHyperthermic RadiochemotherapyHyperthermic ChemoradiotherapyDeep Regional Hyperthermia
Interventions
OTHER

Deep regional hyperthermia

Deep regional hyperthermia of the pelvis, Total time 90 min, Target temperature 41-42°C.

RADIATION

Radiotherapy

Radiotherapy of the primary tumor and pelvis, 5 x 1,8 Gy per week, total Dose: 50,4 Gy.

DRUG

Chemotherapy (5-Fluorouracil)

5-Fluorouracil, continuous venous infusion week 1 and 5. 1000 mg per square meter of body-surface area per day.

Trial Locations (1)

72076

University Hospital Tübingen, Department of Radiation Oncology, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT02353858 - Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter